Found: 224
Select item for more details and to access through your institution.
Population Pharmacokinetics of Tofacitinib in Patients With Moderate to Severe Ulcerative Colitis.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 3, p. 229, doi. 10.1002/cpdd.899
- By:
- Publication type:
- Article
The ClC-2 Chloride Channel Activator, Lubiprostone, Improves Intestinal Barrier Function in Biopsies from Crohn's Disease but Not Ulcerative Colitis Patients.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 3, p. 811, doi. 10.3390/pharmaceutics15030811
- By:
- Publication type:
- Article
The Pharmacokinetics and Colonic Tissue Concentrations of Cyclosporine After IV, Oral, and Enema Administration.
- Published in:
- 1991
- By:
- Publication type:
- Other
Pharmacokinetics and Pharmacodynamics of Oral and Intravenous Cimetidine in Seriously III Patients.
- Published in:
- 1990
- By:
- Publication type:
- Other
Renal and Urologic Complications of Inflammatory Bowel Disease.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 1998, v. 93, n. 4, p. 504, doi. 10.1111/j.1572-0241.1998.156_b.x
- By:
- Publication type:
- Article
Clinical Outcome Following Treatment of Refractory Inflammatory and Fistulizing Crohn's Disease With Intravenous Cyclosporine.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 1998, v. 93, n. 3, p. 442, doi. 10.1111/j.1572-0241.1998.00442.x
- By:
- Publication type:
- Article
Preliminary Report on the Use of Oral Tacrolimus (FK506) in the Treatment of Complicated Proximal Small Bowel and Fistulizing Crohn's Disease.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 1997, v. 92, n. 5, p. 876
- By:
- Publication type:
- Article
A Review of Immune Modifier Therapy for Inflammatory Bowel Disease: Azathioprine, 6-Mercaptopurine, Cyclosporine, and Methotrexate.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 1996, v. 91, n. 3, p. 423
- By:
- Publication type:
- Article
Clinical Response Does Not Correlate with Intestinal or Blood Cyclosporine Concentrations in Patients with Crohn's Disease Treated with High-Dose Oral Cyclosporine.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 1996, v. 91, n. 1, p. 37
- By:
- Publication type:
- Article
Pouchitis Disease Course after Orthotopic Liver Transplantation in Patients with Primary Sclerosing Cholangitis and an Heal Pouch--Anal Anastomosis.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 1995, v. 90, n. 12, p. 2177
- By:
- Publication type:
- Article
Collagenous and Lymphocytic Colitis: Subject Review and Therapeutic Alternatives.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 1995, v. 90, n. 9, p. 1394
- By:
- Publication type:
- Article
Antineutrophil Cytoplasmic Antibody Correlates with Chronic Pouchitis after Heal Pouch-Anal Anastomosis.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 1995, v. 90, n. 5, p. 740
- By:
- Publication type:
- Article
Cyclosporine Enemas for Treatment-Resistant, Mildly to Moderately Active, Left-Sided Ulcerative Colitis.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 1993, v. 88, n. 5, p. 640
- By:
- Publication type:
- Article
Artificial intelligence-rationalized balanced PPARα/γ dual agonism resets dysregulated macrophage processes in inflammatory bowel disease.
- Published in:
- Communications Biology, 2022, v. 5, n. 1, p. 1, doi. 10.1038/s42003-022-03168-4
- By:
- Publication type:
- Article
A randomised, double‐blind, placebo‐controlled study of the LAG‐3‐depleting monoclonal antibody GSK2831781 in patients with active ulcerative colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 3, p. 283, doi. 10.1111/apt.17557
- By:
- Publication type:
- Article
Real‐world multicentre observational study including population pharmacokinetic modelling to evaluate the exposure–response relationship of vedolizumab in inflammatory bowel disease: ERELATE Study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 3, p. 463, doi. 10.1111/apt.16937
- By:
- Publication type:
- Article
Editorial: protecting hypoxia‐inducible factor 1a and gut integrity with GB004—a promising therapeutic approach for ulcerative colitis? Authors' reply.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Cover Image.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 4, p. i, doi. 10.1111/apt.16823
- By:
- Publication type:
- Article
Randomised clinical trial: a phase 1b study of GB004, an oral HIF‐1α stabiliser, for treatment of ulcerative colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 4, p. 401, doi. 10.1111/apt.16753
- By:
- Publication type:
- Article
Safety and efficacy of tofacitinib for treatment of ulcerative colitis: final analysis of OCTAVE Open, an open‐label, long‐term extension study with up to 7.0 years of treatment.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 4, p. 464, doi. 10.1111/apt.16712
- By:
- Publication type:
- Article
Agreement between local and central reading of endoscopic disease activity in ulcerative colitis: results from the tofacitinib OCTAVE trials.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 11, p. 1442, doi. 10.1111/apt.16626
- By:
- Publication type:
- Article
An expert consensus to standardise clinical, endoscopic and histologic items and inclusion and outcome criteria for evaluation of pouchitis disease activity in clinical trials.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 10, p. 1108, doi. 10.1111/apt.16328
- By:
- Publication type:
- Article
An expert consensus to standardise the assessment of histological disease activity in Crohn's disease clinical trials.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 7, p. 784, doi. 10.1111/apt.16248
- By:
- Publication type:
- Article
Systematic review with meta‐analysis: safety and tolerability of immune checkpoint inhibitors in patients with pre‐existing inflammatory bowel diseases.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 3, p. 374, doi. 10.1111/apt.16217
- By:
- Publication type:
- Article
Ustekinumab is effective and safe for ulcerative colitis through 2 years of maintenance therapy.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 11/12, p. 1658, doi. 10.1111/apt.16119
- By:
- Publication type:
- Article
Evaluating the optimum number of biopsies to assess histological inflammation in ulcerative colitis: a retrospective cohort study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 10, p. 1574, doi. 10.1111/apt.16083
- By:
- Publication type:
- Article
Long‐term safety of vedolizumab for inflammatory bowel disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 8, p. 1353, doi. 10.1111/apt.16060
- By:
- Publication type:
- Article
Predictors and outcomes of histological remission in ulcerative colitis treated to endoscopic healing.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 6, p. 1008, doi. 10.1111/apt.16026
- By:
- Publication type:
- Article
Letter: combination of biologics in inflammatory bowel diseases. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 3, p. 568, doi. 10.1111/apt.15919
- By:
- Publication type:
- Article
No benefit of continuing vs stopping 5‐aminosalicylates in patients with ulcerative colitis escalated to anti‐metabolite therapy.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 3, p. 481, doi. 10.1111/apt.15876
- By:
- Publication type:
- Article
Artificial intelligence guided discovery of a barrier-protective therapy in inflammatory bowel disease.
- Published in:
- Nature Communications, 2021, v. 8, p. 1, doi. 10.1038/s41467-021-24470-5
- By:
- Publication type:
- Article
Relationships between C-reactive protein concentration and genotype in healthy volunteers.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2009, v. 47, n. 1, p. 20, doi. 10.1515/CCLM.2009.005
- By:
- Publication type:
- Article
Tailoring Treatment to the Individual Patient: Drug Monitoring.
- Published in:
- Digestive Diseases, 2014, v. 32, p. 88, doi. 10.1159/000367834
- By:
- Publication type:
- Article
Deep Remission: A New Concept?
- Published in:
- Digestive Diseases, 2013, v. 30, p. 107, doi. 10.1159/000342732
- By:
- Publication type:
- Article
The Future of Inflammatory Bowel Disease Therapy: Where Do We Go from Here?
- Published in:
- Digestive Diseases, 2013, v. 30, p. 140, doi. 10.1159/000342742
- By:
- Publication type:
- Article
The Future of Inflammatory Bowel Disease Therapy: Where Do We Go from Here?
- Published in:
- Digestive Diseases, 2012, v. 30, p. 140, doi. 10.1159/000342742
- By:
- Publication type:
- Article
Deep Remission: A New Concept?
- Published in:
- Digestive Diseases, 2012, v. 30, p. 107, doi. 10.1159/000342732
- By:
- Publication type:
- Article
State-of-the-Art: Immunosuppression and Biologic Therapy.
- Published in:
- Digestive Diseases, 2010, v. 28, n. 3, p. 536, doi. 10.1159/000320413
- By:
- Publication type:
- Article
How to Avoid Treating Irritable Bowel Syndrome with Biologic Therapy for Inflammatory Bowel Disease.
- Published in:
- Digestive Diseases, 2010, v. 27, p. 80, doi. 10.1159/000268125
- By:
- Publication type:
- Article
Innovations in Oral Therapies for Inflammatory Bowel Disease.
- Published in:
- Drugs, 2019, v. 79, n. 12, p. 1321, doi. 10.1007/s40265-019-01169-y
- By:
- Publication type:
- Article
Systemic and intestinal pharmacokinetics of methotrexate in patients with inflammatory bowel disease<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1999, v. 65, n. 1, p. 29, doi. 10.1016/S0009-9236(99)70119-0
- By:
- Publication type:
- Article
Pharmacokinetics of nicotine carbomer enemas: A new treatment modality for ulcerative colitis.
- Published in:
- Clinical Pharmacology & Therapeutics, 1997, v. 61, n. 3, p. 340, doi. 10.1016/S0009-9236(97)90167-3
- By:
- Publication type:
- Article
Antineutrophil Cytoplasmic Antibody Subtypes in Children and Adolescents After Ileal Pouch-Anal Anastomosis for Ulcerative Colitis.
- Published in:
- Journal of Pediatric Gastroenterology & Nutrition, 1998, v. 26, n. 4, p. 386
- By:
- Publication type:
- Article
Measurement of colonic tissue cyclosporine concentration in children with severe ulcerative colitis.
- Published in:
- 1992
- By:
- Publication type:
- journal article
Similar pharmacokinetics of three dosing regimens comprising two oral delayed‐release mesalamine formulations in healthy adult volunteers: Randomised, open‐label, parallel‐group study.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 3, p. 1141, doi. 10.1111/bcp.14479
- By:
- Publication type:
- Article
Primary sclerosing cholangitis and colorectal carcinoma in patients with chronic ulcerative colitis: a case-control study.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Host engulfment pathway controls inflammation in inflammatory bowel disease.
- Published in:
- FEBS Journal, 2020, v. 287, n. 18, p. 3967, doi. 10.1111/febs.15236
- By:
- Publication type:
- Article
Comparative Risk of Cardiovascular Events With Biologic and Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Omega-3 Free Fatty Acids for the Maintenance of Remission in Crohn Disease.
- Published in:
- JAMA: Journal of the American Medical Association, 2008, v. 299, n. 14, p. 1690, doi. 10.1001/jama.299.14.1690
- By:
- Publication type:
- Article
Diagnosis and Treatment of Perianal Fistulas in Crohn Disease.
- Published in:
- Annals of Internal Medicine, 2001, v. 135, n. 10, p. 906, doi. 10.7326/0003-4819-135-10-200111200-00011
- By:
- Publication type:
- Article